Jasper Therapeutics GAAP EPS of -$1.74 misses by $0.40

* Jasper Therapeutics press release [https://seekingalpha.com/pr/20200184-jasper-therapeutics-reports-second-quarter-2025-financial-results-and-provides-corporate] (NASDAQ:JSPR [https://seekingalpha.com/symbol/JSPR]): Q2 GAAP EPS of -$1.74 misses by $0.40.
* Cash and cash equivalents as of June 30, 2025, totaled $39.5 million.

MORE ON JASPER THERAPEUTICS

* Seeking Alpha’s Quant Rating on Jasper Therapeutics [https://seekingalpha.com/symbol/JSPR/ratings/quant-ratings]
* Historical earnings data for Jasper Therapeutics [https://seekingalpha.com/symbol/JSPR/earnings]
* Financial information for Jasper Therapeutics [https://seekingalpha.com/symbol/JSPR/income-statement]